Editas Medicine nets $43 mln in Series A funds

Editas Medicine said Monday that it has closed $43 million in Series A financing. Flagship Ventures, Polaris Partners and Third Rock Ventures led the round with participation from Partners Innovation Fund. Based in Cambridge, Mass., Editas Medicine is a provider of transformative genome editing solutions.

North AmericaUSBriefs